Leadership Team

RALPH LLOYD-ROBERTS, CEO

RALPH LLOYD-ROBERTS, CEO

An IT professional of some 25 years experience in the field of systems architecture and development, database design and administration. He worked in the financial services sector for 10 years running a team of database technical specialists where he developed strong leadership and team building skills. He has been solely responsible for building the cloud-based system required to calculate CVT in real time and outside of the clinical environment.

KERSTIN SALLOWS, EXECUTIVE CHAIR

KERSTIN SALLOWS, EXECUTIVE CHAIR

A career spanning over 34 years of international investment experience, holding senior positions with Deutsche Bank and BZW in Frankfurt, London and Sydney prior to joining AMP Private Capital,  the then largest investor in the Southern Hemisphere, as a Director of the Private Capital Division.  Kerstin founded Alternative Asset Manager Brookvine in 2001 that was successfully sold to a listed entity in 2022.

KEITH DAVIDSON, COO
AND DIRECTOR OF MARKETING

Formerly EMEA Regional Director at Saatchi & Saatchi, Keith was responsible for the development and execution of global and regional marketing strategies for the agency’s largest client, Procter & Gamble. This involved centralised strategic and budgetary management of third party suppliers, as well as setting up, training and directing agency teams in multiple countries, ensuring the highest level of client service. Keith also co-founded a retail brand company in 2014.

IAN WYNNE, DIRECTOR OF RESEARCH & HUMAN PERFORMANCE

IAN WYNNE, DIRECTOR OF RESEARCH
& HUMAN PERFORMANCE

Over 20 years of experience exploring and developing human potential, a successful Olympic athlete, followed by 9 years of elite coaching with world-class athletes, Independent Performance Consultant, and now Director of Research and Human Performance for PBM. The key point of contact for clients, Ian has extensive knowledge and practical experience of applying CVT within the field of human performance and research and has become the company’s non-clinical expert on it.

Medical Advisory Board

 
Screenshot 2021-02-07 at 15.09.23.png

DR PETER JULU (MBChB, MSc, PhD, FPhysiol, FRCP)

Leading world expert in autonomic neurophysiology. He practices clinically and carries out cutting-edge clinical neurophysiological research, both internationally and in the UK. Dr Julu is the inventor of the NeuroScope, a machine for autonomic assessment and monitoring of brainstem functions

Screenshot 2021-02-07 at 15.12.40.png

PROFESSOR MELVIN LOBO (MBChB PhD FRCP FBHS FESC FACC)

A pioneering cardiovascular specialist based in London. Considered a global thought leader for his work as a specialist in all forms of blood pressure disorders. He has been involved in a number of important clinical studies of device-based therapies for these conditions

Dr Shane Delamont.jpeg

DR SHANE DELAMONT (MB BS, MD, FRACP, FRCP)

Consultant Neurologist with specialist interest in the diagnosis and management of epilepsy, syncope and seizure-like attacks. He specialised in epilepsy and cardiovascular autonomic function before his appointment at King’s as consultant neurologist. He is also honorary senior lecturer at King’s College London